Organisation paid for research Program year 2020 Source: CMS Open Payments

Altru Cancer Ctr

Neither a doctor nor a teaching hospital

Research payments

$160,985

2 payments

Through program year 2020, Altru Cancer Ctr is reported as receiving $160,985 in research payments, across 2 payments.

By program year

2 rows
Year Kind Amount Payments
2020 Research $28,878 1
2019 Research $132,107 1

Breakdown

Who paid Research payments · program years 2019–2020
  1. Boehringer Ingelheim Pharmaceuticals, Inc. $160,985 2 payments
Studies the money was for Research payments · program years 2019–2020
  1. randomized & cetuximab vs afa alone $160,985 2 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.

Provenance

Source: CMS Open Payments · through program year 2020

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record